After complaints over five price hikes since 2009, Mylan, the manufacturer of EpiPen, the rapid response allergy shot is introducing a generic version of the drug.
The pharmaceutical company said the alternate drug will be released in several weeks for $300 for a two-pack of dosages, about half the price of the current drug.
Here & Now's Jeremy Hobson speaks with Jill Schlesinger of CBS News, about the allergy injection pen uproar.
This segment aired on August 29, 2016.
- Mylan to offer generic EpiPen for 50% less
- Mylan to Offer a Generic EpiPen at Half the Price
- A Push To Make Flying Safer For People With Peanut Allergies